MedTrace Logo

Sucralose in Subjects With Diabetes Mellitus Insulin Requesting

NCT02813759 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2016-06-27

No results posted yet for this study

Summary

To evaluate the acute effect of a preload of sucralose in presence of carbohydrate (HC) available on the glycemic response, postprandial C peptide and satiety in patients with type 2 diabetes mellitus (DM2) in intensive insulin therapy (IIT).

Conditions

  • Diabetes Mellitus, Type 2

Interventions

OTHER

Sucralose

Subjects drank 200 mL of water with 14 mg sucralose, followed by a standard breakfast.

OTHER

Placebo

Subjects drank 200 mL of water alone (placebo), followed by a standard breakfast.

Sponsors & Collaborators

  • Universidad de Valparaiso

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
35 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2015-11-30
Completion
2016-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02813759 on ClinicalTrials.gov